NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 100 filers reported holding NUVALENT INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $56,975,356 | -6.2% | 1,239,403 | -14.0% | 0.74% | -3.4% |
Q2 2023 | $60,755,584 | +66.0% | 1,440,730 | +2.7% | 0.77% | +49.2% |
Q1 2023 | $36,591,877 | -26.6% | 1,402,525 | -16.2% | 0.51% | -30.8% |
Q4 2022 | $49,828,313 | +62.6% | 1,673,214 | +6.1% | 0.74% | +60.1% |
Q3 2022 | $30,644,000 | +61.1% | 1,576,326 | +12.4% | 0.46% | +50.6% |
Q2 2022 | $19,017,000 | +18.0% | 1,402,451 | +20.9% | 0.31% | +55.6% |
Q1 2022 | $16,113,000 | -28.3% | 1,160,068 | -1.7% | 0.20% | -13.5% |
Q4 2021 | $22,480,000 | -5.3% | 1,180,696 | +12.2% | 0.23% | -18.5% |
Q3 2021 | $23,731,000 | – | 1,052,394 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $436,140,000 | 8.51% |
Fairmount Funds Management LLC | 914,614 | $20,625,000 | 7.50% |
Bain Capital Life Sciences Investors, LLC | 3,428,014 | $77,302,000 | 4.80% |
VR Adviser, LLC | 803,951 | $18,129,000 | 2.33% |
Boxer Capital, LLC | 1,210,192 | $27,290,000 | 0.95% |
BVF INC/IL | 448,512 | $10,114,000 | 0.40% |
Avoro Capital Advisors LLC | 1,257,671 | $22,288,000 | 0.35% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,052,394 | $23,731,000 | 0.28% |
Perceptive Advisors | 750,000 | $16,913,000 | 0.25% |
Logos Global Management LP | 134,650 | $2,733,000 | 0.20% |